Imidazopiperazine inhibitors of transcription activating proteins
US12186324B2 · kind B2 · utility
0Cited by
6References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2021 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Jun 16, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.